Abstract: A drive circuit for a plurality of piezo-actuated hydraulic pumps for an aircraft, and a hydraulic pump system implementing the same. The drive circuit includes a voltage boost stage that receives a DC input supply voltage and delivers an increased DC output voltage to a high voltage, HV, link point; a plurality of inverter stages coupled in parallel at the HV link point that receive DC voltage from the HV link point and generate an oscillating output voltage for driving a respective piezo-actuated pump; and a control system that controls the output voltage and phase of the inverter stages to drive the plurality of piezo-actuated pumps out of phase. The control system measures the power consumption of each piezo-actuated pump and regulates the output voltage of at least one of the inverter stages to balance the power consumption of each piezo-actuated pump.

Abstract: A system and method for managing raw files are disclosed. A plurality of image files associated with one or more raw files that include respective metadata are evaluated. A set of one or more of the images files are grouped together based on matching the respective metadata. An asset file corresponding to the raw file and the grouped set of the image files are generated. The asset file are retrieved in response to a request from a user device. At least one of the image files in the grouped set are selected and a display of the selected image file is generated for rendering.

Abstract: Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for treating diseases associated with hyperammonemia, e.g., urea cycle disorders (UCD) and hepatic encephalopathy (HE), e.g., minimal HE (MHE) and overt HE (OHE), and modulating enzyme activities and levels of microbes and taxa, and metabolites (e.g., ammonia) in the microbiome of a subject.

Abstract: In some aspects, fusosome compositions and methods are described herein that comprise membrane enclosed preparations, comprising a fusogen. In some embodiments, the fusosome can fuse to the target cell, thereby delivering complex biologic agents to the target cell cytoplasm.

Abstract: The present disclosure relates generally to compositions of synthetic bifunctional molecules comprising a first domain that specifically binds to a target ribonucleic acid sequence and a second domain that specifically binds to a target protein, and uses thereof.

Abstract: Processes, as well as associated systems and computer program (software) products, are disclosed for the biological conversion of CO into desired end products such as ethanol. The control methodologies used for these processes can advantageously result in a reduced time required for a batch operation or other initial operating period, prior to achieving a continuous operation, which may be demarcated either by the addition of fresh culture medium at a defined flow rate or by another process initiation target. The control methodologies may alternatively, or in combination, improve a process performance parameter, such as productivity of the desired end product or bacterial growth rate, during this batch operation or other initial operating period.

Abstract: The present disclosure relates generally to compositions of synthetic bifunctional molecules comprising a first domain that specifically binds to a target ribonucleic acid and a second domain that specifically binds to a target protein, and uses thereof.

Abstract: The present disclosure relates generally to compositions of synthetic bifunctional molecules comprising a first domain that specifically binds to a target ribonucleic acid and a second domain that specifically binds to a target polypeptide, and uses thereof.

Abstract: In some aspects, fusosome compositions and methods are described herein that comprise membrane enclosed preparations, comprising a fusogen. In some embodiments, the fusosome can the target cell, thereby delivering complex biologic agents to the target cell cytoplasm.

Abstract: A vehicle component such as an axle spindle or suspension beam (3) is connected to a tubular vehicle axle (1) by fitting a connector sleeve (2) onto the axle and subjecting the assembly to a crimping operation in which plural depressions (206,2018) are formed by indentation in the connector sleeve and the axle wall at the connection region (11,12) to fix the connector sleeve on the tubular axle. In the described proposals a solid lubricant (4) such as molybdenum disulphide is applied at the connection region between the connector sleeve (2) and axle (1), before crimping. The further vehicle component (3) is then connected to the connector sleeve (2) by welding.

Abstract: Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for treating diseases associated with hyperammonemia, e.g., urea cycle disorders (UCD) and hepatic encephalopathy (HE), e.g., minimal HE (MHE) and overt HE (OHE), and modulating enzyme activities and levels of microbes and taxa, and metabolites (e.g., ammonia) in the microbiome of a subject.

Abstract: This disclosure provides, e.g., cytobiologic compositions and methods of use thereof. The cytobiologics can be used, e.g., to deliver a protein or nucleic acid to a target cell.

Abstract: An axle/suspension system (1) has an axle (5) supported from the frame of the vehicle by a pair of rigid longitudinal beams (4) pivoted to frame hangers (3). Air springs (7) and shock absorbers (8) connect between the rigid beams (4) and the frame above to control suspension movement. The axle/suspension system is particularly suited as a mid-lift axle on the tractor of a tractor-trailer vehicle. A characteristic feature is the pivotal connection (21) between each hanger (3) and beam (4), which is through a resilient bush (6) having a compliance ratio—being a ratio of the longitudinal spring rate to the vertical spring rate—of at least 10:1.

Abstract: A vehicle component such as an axle spindle or suspension beam (3) is connected to a tubular vehicle axle (1) by fitting a connector sleeve (2) onto the axle and subjecting the assembly to a crimping operation in which plural depressions (206,2018) are formed by indentation in the connector sleeve and the axle wall at the connection region (11,12) to fix the connector sleeve on the tubular axle. In the described proposals a solid lubricant (4) such as molybdenum disulphide is applied at the connection region between the connector sleeve (2) and axle (1), before crimping. The further vehicle component (3) is then connected to the connector sleeve (2) by welding.

Abstract: In some aspects, fusosome compositions and methods are described herein that comprise membrane enclosed preparations, comprising a fusogen. In some embodiments, the fusosome can the target cell, thereby delivering complex biologic agents to the target cell cytoplasm.

Abstract: The present invention provides, among other things, systems (e.g., comprising compositions and/or methods) for diagnosis, prophylaxis, treatment, prevention, and/or characterization of influenza transmission and/or infection. The present invention also provides methods for monitoring influenza variants for their potential to present a pandemic risk to humans.

Abstract: An axle/suspension system (1) has an axle (5) supported from the frame of the vehicle by a pair of rigid longitudinal beams (4) pivoted to frame hangers (3). Air springs (7) and shock absorbers (8) connect between the rigid beams (4) and the frame above to control suspension movement. The axle/suspension system is particularly suited as a mid-lift axle on the tractor of a tractor-trailer vehicle. A characteristic feature is the pivotal connection (21) between each hanger (3) and beam (4), which is through a resilient bush (6) having a compliance ratio—being a ratio of the longitudinal spring rate to the vertical spring rate—of at least 10:1.

Abstract: Processes, as well as associated systems and computer program (software) products, are disclosed for the biological conversion of CO into desired end products such as ethanol. The control methodologies used for these processes can advantageously result in a reduced time required for a batch operation or other initial operating period, prior to achieving a continuous operation, which may be demarcated either by the addition of fresh culture medium at a defined flow rate or by another process initiation target. The control methodologies may alternatively, or in combination, improve a process performance parameter, such as productivity of the desired end product or bacterial growth rate, during this batch operation or other initial operating period.

Abstract: Processes, as well as associated systems and computer program (software) products, are disclosed for the biological conversion of CO into desired end products such as ethanol. The control methodologies used for these processes can advantageously result in a reduced time required for a batch operation or other initial operating period, prior to achieving a continuous operation, which may be demarcated either by the addition of fresh culture medium at a defined flow rate or by another process initiation target. The control methodologies may alternatively, or in combination, improve a process performance parameter, such as productivity of the desired end product or bacterial growth rate, during this batch operation or other initial operating period.

Abstract: Processes, as well as associated systems and computer program (software) products, are disclosed for the biological conversion of CO into desired end products such as ethanol. The control methodologies used for these processes can advantageously result in a reduced time required for a batch operation or other initial operating period, prior to achieving a continuous operation, which may be demarcated either by the addition of fresh culture medium at a defined flow rate or by another process initiation target. The control methodologies may alternatively, or in combination, improve a process performance parameter, such as productivity of the desired end product or bacterial growth rate, during this batch operation or other initial operating period.